| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |